Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.08
- Piotroski Score 2.00
- Grade Market Outperform
- Symbol (STIM)
- Company Neuronetics, Inc.
- Price $1.17
- Changes Percentage (8.37%)
- Change $0.09
- Day Low $1.08
- Day High $1.18
- Year High $5.07
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $8.00
- High Stock Price Target $8.00
- Low Stock Price Target $8.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.94
- Trailing P/E Ratio -2.38
- Forward P/E Ratio -2.38
- P/E Growth -2.38
- Net Income $-30,189,000
Income Statement
Quarterly
Annual
Latest News of STIM
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Vedanta Profit Beats Estimates Boosted by Metals, One-time Gain
Vedanta Ltd. reported a net profit of 43.5 billion rupees for the September quarter, driven by higher metals revenue and write-backs. Earnings recovery eased debt concerns at Vedanta Resources Ltd. as...
By Yahoo! Finance | 11 hours ago -
China's stimulus plans are choking the profitability of its megabanks, analysts say
China's largest state-owned banks face declining profit margins due to Beijing's stimulus measures. Net interest margins at major lenders like ICBC and Bank of China have dropped significantly, impact...
By CNBC | 14 hours ago -
Asia stocks sputter as focus shifts to China stimulus
By Kevin BucklandTOKYO (Reuters) -Asian stocks pared early gains on Friday as investors cautiously turned their focus to stimulus announcements from China later in the day with Beijing's week-long leg...
By Reuters | 15 hours ago
